StockNews.com Begins Coverage on ObsEva (NASDAQ:OBSV)

Equities researchers at StockNews.com started coverage on shares of ObsEva (NASDAQ:OBSV) in a note issued to investors on Sunday. The brokerage set a “hold” rating on the stock.

ObsEva Stock Performance

The business has a 50-day simple moving average of $0.01. The stock has a market capitalization of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68. ObsEva has a twelve month low of $0.08 and a twelve month high of $2.14.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.